Professor, Pathology (Clinical), Case Western Reserve University School of Medicine
Pathology
Dr. Eric D. Hsi, MD
|
|
Give Review
Eric D. Hsi, MD practices Pathology. He graduated from University of Michigan Medical School. Eric is a published doctor and has 100 publications published. The lastest was: 'Dual institution experience of extranodal marginal zone lymphoma reveals excellent long-term outcomes.' He accepts Medicare.
Publications
- Dual institution experience of extranodal marginal zone Lymphoma reveals excellent long-term outcomes.
- Angioimmunoblastic T-cell Lymphomas With the RHOA p.Gly17Val Mutation Have Classic Clinical and Pathologic Features.
- Stratifying diffuse large B-cell Lymphoma patients treated with chemoimmunotherapy: GCB/non-GCB by immunohistochemistry is still a robust and feasible marker.
- Clinical features, tumor biology, and prognosis associated with MYC rearrangement and Myc overexpression in diffuse large B-cell Lymphoma patients treated with rituxim...
- Prognostic impact of concurrent MYC and BCL6 rearrangements and expression in de novo diffuse large B-cell Lymphoma.
- Screening for SF3B1 mutations is a useful tool to differentiate between acquired clonal and non-clonal sideroblastic Anemia.
- Clinical Implications of Phosphorylated STAT3 Expression in De Novo Diffuse Large B-cell Lymphoma.
- Combination of ibrutinib with ABT-199: synergistic effects on proliferation inhibition and apoptosis in mantle cell Lymphoma cells through perturbation of BTK, AKT and...
- Utility and Diagnostic Pitfalls of SOX11 Monoclonal Antibodies in Mantle Cell Lymphoma and Other Lymphoproliferative Disorders.
- Frequency, interobserver reproducibility and clinical significance of equivocal peaks in PCR clonality testing using Euroclonality/BIOMED-2 primers.
- De novo Acute myeloid leukemia with 20-29% blasts is less aggressive than Acute myeloid leukemia with â¥30% blasts in older adults: A Bone Marrow Pathology Group study.
- ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous Disease with widely disparate clinical outcomes.
- Molecular subtype classification of formalin-fixed, paraffin-embedded diffuse large B-cell Lymphoma samples on the ICEPlex(®) system.
- PDGFRB-rearranged T-lymphoblastic Leukemia/lymphoma occurring with myeloid neoplasms: The missing link supporting a stem cell origin.
- Flow cytometric analysis of cerebrospinal fluid has low diagnostic yield in samples without atypical morphology or prior history of hematologic malignancy.
- PRPF8 defects cause missplicing in Myeloid malignancies.
- The genomic landscape of mantle cell lymphoma is related to the epigenetically determined chromatin State of normal B cells.
- Diagnostic Accuracy of a Defined Immunophenotypic and Molecular Genetic Approach for Peripheral T/NK-cell Lymphomas: A North American PTCL Study Group Project.
- Prevalence and clinical implications of cyclin D1 expression in diffuse large B-cell Lymphoma (DLBCL) treated with immunochemotherapy: A report from the International ...
- Atypical chronic myeloid Leukemia (aCML) BCR-ABL1-negative is clinicopathologically distinct from unclassifiable myelodysplastic/myeloproliferative neoplasms (MDS/MPN-...
- Prevalence and Clinical Implications of Epstein-Barr Virus Infection in de novo Diffuse Large B-Cell Lymphoma in Western Countries.
- Undiagnosed mycosis fungoides with transformation to large cell peripheral T-cell Lymphoma.
- Rearrangements of MYC gene facilitate risk stratification in diffuse large B-cell Lymphoma patients treated with rituximab-CHOP.
- MYD88 L265P Somatic Mutation: Its Usefulness in the Differential Diagnosis of Bone Marrow Involvement by B-Cell Lymphoproliferative Disorders.
- Indolent mantle cell Lymphoma.
- A phase 2 trial of extended induction epratuzumab and rituximab for previously untreated follicular Lymphoma: CALGB 50701.
- MDM2 phenotypic and genotypic profiling, respective to TP53 genetic status, in diffuse large B-cell Lymphoma patients treated with rituximab-CHOP immunochemotherapy.
- The phosphatidylinositol 3-kinases (PI3K) inhibitor GS-1101 synergistically potentiates histone deacetylase inhibitor-induced proliferation inhibition and apoptosis th...
- Chromosomal Rearrangements of 6p25.3 Define a New Subtype of Lymphomatoid Papulosis.
- Intensive Chemotherapy and Immunotherapy in Patients With Newly Diagnosed Primary CNS Lymphoma: CALGB 50202 (Alliance 50202).
- Single nucleotide variation in the TP53 3' untranslated region in diffuse large B-cell Lymphoma treated with rituximab-CHOP: a report from the International DLBCL Ritu...
- MYC/BCL2 protein co-expression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell Lymphoma and demonstrates high-risk gene expres...
- Phospho-ERK(THR202/Tyr214) is overexpressed in hairy cell Leukemia and is a useful diagnostic marker in bone marrow trephine sections.
- Expression of TweakR in breast cancer and preclinical activity of enavatuzumab, a humanized anti-TweakR mAb.
- Genetic heterogeneity of diffuse large B-cell Lymphoma.
- CD30 expression defines a novel subset of diffuse large B-cell Lymphoma with favorable prognosis and distinct gene expression signature: a report from The Internationa...
- Expression of phosphorylated signal transducer and activator of transcription 5 is associated with an increased risk of death in Acute myeloid leukemia.
- Cyclin D1-negative Blastoid Mantle Cell Lymphoma Identified by SOX11 Expression.
- Detection of minimal residual Disease following inductionimmunochemotherapy predicts progression free survival inmantle cell lymphoma: final results of CALGB 59909.
- Clonal drift demonstrates unexpected dynamics of the T-cell repertoire in T-large granular lymphocyte Leukemia.
- Mutational spectrum analysis of chronic myelomonocytic Leukemia includes genes associated with epigenetic regulation: UTX, EZH2 and DNMT3A.
- Plasmablastic Lymphoma and related disorders.
- Plasma Cell myeloma and related neoplasms.
- HDAC inhibitors potentiate the apoptotic effect of enzastaurin in Lymphoma cells.
- MicroRNA expression in diffuse large B-cell Lymphoma treated with chemoimmunotherapy.
- Cancer and Leukemia Group B Pathology Committee Guidelines for Tissue Microarray Construction Representing Multicenter Prospective Clinical Trial Tissues.
- Indolent mantle cell Leukemia: clinicopathologic variant characterized by isolated lymphocytosis, interstitial bone marrow involvement, kappa light chain restriction, ...
- Follicular programmed death 1-positive lymphocytes in the tumor microenvironment are an independent prognostic factor in follicular Lymphoma.
- Specificity of IRF4 translocations for primary cutaneous anaplastic large cell Lymphoma: a multicenter study of 204 skin biopsies.
- Idiopathic systemic capillary leak Syndrome preceding diagnosis of infiltrating lobular carcinoma of the breast with quiescence during neoadjuvant chemotherapy.
- Doxorubicin, vinblastine, gemcitabine (CALGB 50203) for stage I/II non-bulky Hodgkin Lymphoma: pretreatment prognostic factors and interim PET.
- Predicting hematopoietic stem Cell mobilization failure in patients with multiple myeloma: A simple method using day 1 CD34+ Cell yield.
- Selection and validation of antibodies for signal transduction immunohistochemistry.
- Clinical roundtable monograph. The management of aggressive T-cell Lymphoma: a discussion on transformed mycosis fungoides.
- Clinical roundtable monograph. T-cell lymphoma: therapeutic overview and Disease state awareness.
- Mammalian target of rapamycin (mTOR) regulates Cellular proliferation and tumor growth in urothelial carcinoma.
- T/NK large granular lymphocyte Leukemia and coexisting monoclonal B-cell lymphocytosis-like proliferations. An unrecognized and frequent association.
- Expression of p21 protein predicts clinical outcome in DLBCL patients older than 60 years treated with R-CHOP but not CHOP: a prospective ECOG and Southwest Oncology G...
- Protocol for the examination of specimens from patients with hematopoietic neoplasms of the ocular adnexa.
- Antibodies to TWEAK receptor inhibit human tumor growth through dual mechanisms.
- Expression of Grb2 distinguishes classical Hodgkin Lymphomas from primary mediastinal B-cell Lymphomas and other diffuse large B-cell Lymphomas.
- Extramedullary plasmacytoma-like posttransplantation lymphoproliferative Disorders: clinical and pathologic features.
- Age-related Epstein-Barr virus-associated lymphoproliferative disorder presenting as renal mass.
- The Leukemias of mature lymphocytes.
- Quantitative in situ detection of phosphoproteins in fixed tissues using quantum dot technology.
- Epstein-Barr virus-positive B-cell lymphoma of the elderly at a United States tertiary medical center: an uncommon aggressive lymphoma with a nongerminal center B-cell...
- The role of biomarkers in the management of patients with Lymphoma: promise versus reality.
- Pathobiology of mature T-cell Lymphomas.
- Phospho-STAT5 expression pattern with the MPL W515L mutation is similar to that seen in Chronic myeloproliferative disorders with JAK2 V617F.
- Expression of HGAL in primary cutaneous large B-cell Lymphomas: evidence for germinal center derivation of primary cutaneous follicular Lymphoma.
- CS1, a potential new therapeutic antibody target for the treatment of multiple Myeloma.
- LMO2 protein expression predicts survival in patients with diffuse large B-cell Lymphoma treated with anthracycline-based chemotherapy with and without rituximab.
- Prognostic significance of VEGF, VEGF receptors, and microvessel density in diffuse large B cell Lymphoma treated with anthracycline-based chemotherapy.
- The ratio of FOXP3+ regulatory T cells to granzyme B+ cytotoxic T/NK cells predicts prognosis in classical Hodgkin Lymphoma and is independent of bcl-2 and MAL express...
- Cytoplasmic localization of phosphorylated STAT5 in human Acute myeloid leukemia is inversely correlated with Flt3-ITD.
- The clinicopathologic spectrum of posttransplantation lymphoproliferative Disorders.
- TCL1 in B-Cell tumors retains its normal b-Cell pattern of regulation and is a marker of differentiation stage.
- Morphologic and immunophenotypic variants of nodal T-cell Lymphomas and T-cell Lymphoma mimics.
- T-cell protein tyrosine phosphatase, distinctively expressed in activated-B-cell-like diffuse large B-cell Lymphomas, is the nuclear phosphatase of STAT6.
- Bone marrow phospho-STAT5 expression in non-CML Chronic myeloproliferative disorders correlates with JAK2 V617F mutation and provides evidence of in vivo JAK2 activation.
- Expression of the human germinal center-associated Lymphoma (HGAL) protein identifies a subset of classic Hodgkin Lymphoma of germinal center derivation and improved s...
- Expression of TRAF1 and nuclear c-Rel distinguishes primary mediastinal large cell Lymphoma from other types of diffuse large B-cell Lymphoma.
- Expression of the B cell-associated transcription factors PAX5, OCT-2, and BOB.1 in Acute myeloid leukemia: associations with B-cell antigen expression and myelomonocy...
- Molecular strategies for detection and quantitation of clonal cytotoxic T-cell responses in aplastic Anemia and myelodysplastic syndrome.
- Refractory Anemia with ringed sideroblasts associated with marked thrombocytosis (RARS-T), another myeloproliferative condition characterized by JAK2 V617F mutation.
- Simian virus 40 in posttransplant lymphoproliferative Disorders.
- Prognostic significance of Bcl-6 protein expression in DLBCL treated with CHOP or R-CHOP: a prospective correlative study.
- MAL is expressed in a subset of Hodgkin Lymphoma and identifies a population of patients with poor prognosis.
- Identification of the JAK2 V617F mutation in Chronic myeloproliferative disorders using FRET probes and melting curve analysis.
- Immunohistochemical analysis identifies two cyclin D1+ subsets of plasma Cell myeloma, each associated with favorable survival.
- The correlation dimension identifies B-Cell immunoglobulin light chain restriction in peripheral blood flow cytometry data.
- Podocalyxin: a marker of blasts in Acute leukemia.
- Response to Pantanowitz et al. Regarding our paper on the utility of the detection of HHV-8 LNA-1 by immunohistochemistry in the diagnosis of Kaposi's sarcoma.
- Expression of bcl-2 in classical Hodgkin''s Lymphoma: an independent predictor of poor outcome.
- ZAP-70 expression in B-Cell hematologic malignancy is not limited to CLL/SLL.
- Pathology of primary cutaneous B-cell Lymphomas: diagnosis and classification.
- A clinicopathologic evaluation of follicular Lymphoma grade 3A versus grade 3B reveals no survival differences.
- Immunohistochemical detection of human herpes virus-8 latent nuclear antigen-1 is useful in the diagnosis of Kaposi sarcoma.
- Acute splenic sequestration crisis resembling sepsis in an adult with hemoglobin SC disease.
Schools
University of Mi Med Sch
University Of Michigan
Conditions Treated
- Acute Leukemia
- Anemia
- Antiphospholipid Syndrome (APS)
- Chronic Myeloid Leukemia (CML)
- View All
Doctors Specialties
- Hematology
- Hematopathology
- Pathology
Accepted Insurances
Education
-
University of Michigan Hospitals and Health Centers -
University of Michigan Medical School
Hospital
-
Cleveland Clinic
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1619934817 |
| Last Name Of The Provider | HSI |
| First Name Of The Provider | ERIC |
| View All |
Similar Doctors
|
Dr. Hillard M. Lazarus, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Candace A. Rich, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Priscilla I. Figueroa, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Julia Boncher, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Deepjot Singh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Eric W. Willis, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Angela M. Collie, MD |
|
|
Dr. Terakeith Lertsburapa, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Youran Zou, MB |